Indivior Pharmaceuticals Inc (INDV) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Total Current Assets | 667M | 652M | 922M | 951M | 883M | 839M | 799M | 864.14M | 795.4M | 1.27B | 1.22B | 1.09B | 1.12B | 1.27B | 1.26B | 1.34B | 1.26B | 1.44B |
| Cash & Short-Term Investments | 175M | 195M | 445M | 510M | 373M | 320M | 318M | 379.06M | 329.75M | 410M | 722M | 689M | 705M | 897.83M | 918M | 936.04M | 939M | 1.1B |
| Cash Only | 175M | 195M | 445M | 510M | 372M | 319M | 288M | 302.05M | 247.81M | 316M | 610M | 592M | 588M | 778.18M | 821M | 858.87M | 874M | 1.1B |
| Short-Term Investments | 0 | 0 | 0 | 0 | 1M | 1M | 30M | 77.01M | 81.94M | 94M | 112M | 97M | 117M | 119.64M | 97M | 77.17M | 65M | 0 |
| Accounts Receivable | 285M | 255M | 272M | 240M | 243M | 254M | 251M | 259M | 249M | 254M | 261M | 240M | 246M | 220M | 215M | 196M | 208M | 215M |
| Days Sales Outstanding | 76.66 | 67.72 | 75.01 | 72.77 | 84.08 | 77.69 | 76.42 | 77.3 | 80.59 | 80.85 | 85.04 | 80.12 | 82.89 | 82.69 | 81.49 | 83.18 | 91.96 | 351.91 |
| Inventory | 152M | 153M | 157M | 149M | 163M | 178M | 178M | 171.03M | 162.88M | 135M | 142M | 131M | 123M | 114.62M | 106M | 100.22M | 91M | 95M |
| Days Inventory Outstanding | 343.13 | 222.81 | 227.03 | 273 | 348.75 | 712 | 232.68 | 192.31 | 356.67 | 249.84 | 273 | 231.14 | 274.17 | 230.64 | 237.15 | 228.96 | 226.22 | 889.1 |
| Other Current Assets | 55M | 15M | 18M | 24M | 48M | 87M | 34M | 37.05M | 22.77M | 444M | 67M | 13M | 22M | 18M | 10M | 101M | 10M | 14M |
| Total Non-Current Assets | 530M | 552M | 496M | 500M | 492M | 481M | 665M | 671.11M | 656.51M | 499M | 632M | 637M | 633M | 512.76M | 407M | 379.83M | 461M | 388M |
| Property, Plant & Equipment | 179M | 170M | 154M | 152M | 141M | 139M | 116M | 107.02M | 111.92M | 124M | 85M | 89M | 88M | 85.46M | 80M | 86.19M | 90M | 95M |
| Fixed Asset Turnover | 1.82x | 2.21x | 2.05x | 2.06x | 1.90x | 2.35x | 2.75x | 2.73x | 2.41x | 2.80x | 3.11x | 3.12x | 2.92x | 2.93x | 2.79x | 2.51x | 2.24x | 2.35x |
| Goodwill | 2M | 0 | 0 | 0 | 0 | 2M | 2M | 2M | 2M | 0 | 0 | 0 | 0 | 378.25K | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 2M | 2M | 7M | 7M | 5M | 188M | 216M | 228M | 13M | 218M | 199M | 200M | 70M | 67M | 73.16M | 78M | 82M |
| Long-Term Investments | 27M | 28M | 28M | 27M | 27M | 26M | 26M | 26M | 25.98M | 41M | 52M | 93M | 98M | 98.53M | 117M | 81.18M | 85M | 0 |
| Other Non-Current Assets | 26M | 26M | 27M | 44M | 38M | 29M | 29M | 30.04M | 28.81M | 28M | 25M | 46M | 46M | 38.21M | 37M | 38.08M | 105M | 106M |
| Total Assets | 1.2B | 1.2B | 1.42B | 1.45B | 1.38B | 1.32B | 1.46B | 1.54B | 1.45B | 1.76B | 1.85B | 1.73B | 1.75B | 1.78B | 1.67B | 1.72B | 1.72B | 1.83B |
| Asset Turnover | 0.26x | 0.27x | 0.22x | 0.21x | 0.20x | 0.21x | 0.20x | 0.20x | 0.18x | 0.16x | 0.15x | 0.16x | 0.14x | 0.14x | 0.14x | 0.13x | 0.12x | 0.12x |
| Asset Growth % | -12.95% | -8.72% | -3.28% | -5.42% | -5.3% | -25.27% | -20.95% | -11.31% | -17.27% | -0.76% | 10.83% | 0.42% | 1.8% | -2.92% | - | - | - | - |
| Total Current Liabilities | 779M | 914M | 965M | 1.06B | 1B | 939M | 962M | 1.01B | 860.35M | 1.29B | 1.24B | 972M | 1.04B | 1.02B | 744M | 788.72M | 728M | 804M |
| Accounts Payable | 0 | 48M | 41M | 50M | 183M | 63M | 50M | 46M | 40M | 39M | 71M | 53M | 36M | 33M | 76M | 107M | 518M | 573M |
| Days Payables Outstanding | - | 63.97 | 67.52 | 203.88 | 251.59 | 226 | 64 | 49.53 | 94.59 | 99.22 | 124 | 80.99 | 79.62 | 113.95 | 210.45 | 748.36 | 1.33K | 5.36K |
| Short-Term Debt | 9M | 39M | 18M | 18M | 18M | 18M | 3M | 3M | 3M | 12M | 11M | 12M | 11M | 3M | 10M | 3M | 11M | 11M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8M | 6.99M | 0 | 0 | 0 | 0 | 9.05M | 0 | 5.01M | 0 | 0 |
| Other Current Liabilities | 770M | 722M | 78M | 934M | -31M | 802M | 826M | 174.16M | 80.36M | 1.16B | 1.15B | 902M | 989M | 391M | 639M | 530M | 188M | 213M |
| Current Ratio | 0.86x | 0.71x | 0.96x | 0.90x | 0.88x | 0.89x | 0.83x | 0.85x | 0.92x | 0.98x | 0.98x | 1.13x | 1.08x | 1.24x | 1.70x | 1.70x | 1.73x | 1.80x |
| Quick Ratio | 0.66x | 0.55x | 0.79x | 0.76x | 0.72x | 0.70x | 0.65x | 0.68x | 0.74x | 0.88x | 0.87x | 0.99x | 0.96x | 1.12x | 1.56x | 1.58x | 1.61x | 1.68x |
| Cash Conversion Cycle | - | 226.56 | 234.52 | 141.89 | 181.24 | 563.69 | 245.1 | 220.08 | 342.66 | 231.48 | 234.04 | 230.27 | 277.44 | 199.38 | 108.19 | -436.22 | -1.01K | -4.12K |
| Total Non-Current Liabilities | 562M | 388M | 658M | 654M | 656M | 728M | 669M | 644.1M | 581.56M | 666M | 637M | 642M | 640M | 702.78M | 700M | 704.53M | 764M | 825M |
| Long-Term Debt | 14M | 290M | 304M | 308M | 311M | 315M | 235M | 235M | 234.82M | 237M | 236M | 236M | 236M | 237M | 237M | 237M | 238M | 239M |
| Capital Lease Obligations | 0 | 22M | 24M | 29M | 30M | 32M | 35M | 33M | 31.98M | 34M | 30M | 33M | 32M | 29M | 29M | 32M | 33M | 36M |
| Deferred Tax Liabilities | 0 | 3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 548M | 73M | 330M | 317M | 315M | 381M | 399M | 376M | 314.76M | 390M | 371M | 373M | 372M | 436.78M | 434M | 434M | 493M | 550M |
| Total Liabilities | 1.34B | 1.3B | 1.62B | 1.71B | 1.66B | 1.67B | 1.63B | 1.66B | 1.44B | 1.96B | 1.88B | 1.61B | 1.68B | 1.73B | 1.44B | 1.49B | 1.49B | 1.63B |
| Total Debt | 23M | 351M | 356M | 366M | 370M | 375M | 284M | 281.04M | 278.79M | 283M | 277M | 281M | 279M | 277M | 276M | 280.61M | 282M | 286M |
| Net Debt | -152M | 156M | -89M | -144M | -2M | 56M | -4M | -21M | 30.98M | -33M | -333M | -311M | -309M | -501.18M | -545M | -578.26M | -592M | -816M |
| Debt / Equity | - | - | - | - | - | - | - | - | 27.90x | - | - | 2.40x | 3.88x | 5.40x | 1.22x | 1.22x | 1.22x | 1.41x |
| Debt / EBITDA | 0.17x | 2.76x | 3.42x | 4.75x | 5.21x | 3.71x | 16.71x | - | 3.48x | 4.04x | - | 4.19x | 4.43x | - | 4.45x | 4.07x | 4.78x | 5.84x |
| Net Debt / EBITDA | -1.09x | 1.23x | -0.86x | -1.87x | -0.03x | 0.55x | -0.24x | - | 0.39x | -0.47x | - | -4.64x | -4.90x | - | -8.79x | -8.38x | -10.03x | -16.65x |
| Interest Coverage | 19.57x | 20.33x | 8.25x | 5.13x | 5.92x | 7.77x | 0.90x | -12.44x | 10.25x | 7.78x | -17.10x | 7.20x | 6.80x | -30.88x | 7.75x | 9.29x | 9.00x | 6.57x |
| Total Equity | -144M | -98M | -207M | -258M | -286M | -348M | -167M | -121.02M | 9.99M | -191M | -24M | 117M | 72M | 51.28M | 227M | 230.5M | 232M | 203M |
| Equity Growth % | 49.65% | 71.84% | -23.95% | -113.19% | -2962.15% | -82.2% | -595.83% | -203.44% | -86.12% | -472.5% | -110.57% | -49.24% | -68.97% | -74.74% | - | - | - | - |
| Book Value per Share | -1.12 | -0.78 | -1.60 | -2.09 | -2.31 | -2.72 | -1.25 | -0.90 | 0.07 | -1.35 | -0.17 | 0.82 | 0.51 | 0.38 | 1.55 | 1.65 | 1.56 | 1.44 |
| Total Shareholders' Equity | -144M | -98M | -207M | -258M | -286M | -348M | -167M | -121.02M | 9.99M | -191M | -24M | 117M | 72M | 51.28M | 227M | 230.5M | 232M | 203M |
| Common Stock | 0 | 62M | 62M | 62M | 62M | 62M | 65M | 67.01M | 67.95M | 68M | 69M | 69M | 69M | 68.37M | 69M | 70.15M | 71M | 70M |
| Retained Earnings | -280M | -243M | -346M | -388M | -406M | -454M | 1.07B | 1.12B | 1.26B | -295M | 1.23B | 1.36B | 1.32B | 1.31B | 1.5B | 1.49B | 1.47B | 1.44B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -29M | -30M | -32M | -33M | -35M | -46M | 0 | -1.32B | -1.32B | -1.35B | -1.34B | -1.32B | -1.33B | -1.34B | -1.35B | -1.33B | -1.32B | -1.31B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |